UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000020223 |
|---|---|
| Receipt number | R000023358 |
| Scientific Title | A prospective study of diagnostic value of IMP3 and p53 immunohistochemical staining in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for pancreatic solid masses |
| Date of disclosure of the study information | 2015/12/17 |
| Last modified on | 2017/08/04 00:42:48 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A prospective study of diagnostic value of IMP3 and p53 immunohistochemical staining in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for pancreatic solid masses
Acronym
A prospective study of diagnostic value of IMP3 and p53 immunohistochemical staining in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for pancreatic solid masses
Scientific Title
A prospective study of diagnostic value of IMP3 and p53 immunohistochemical staining in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for pancreatic solid masses
Scientific Title:Acronym
A prospective study of diagnostic value of IMP3 and p53 immunohistochemical staining in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for pancreatic solid masses
Region
| Japan |
Condition
Condition
pancreatic solid massess
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the usefulness of IMP3 and p53 immunohistochemical staining in the EUS-FNA samples for pancreatic solid masses
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Improvement of the diagnostic accuracy by IMP3 and p53 immunohistochemical staning
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with pancreatic solid mass which is detected by EUS
Key exclusion criteria
1)< 20years old
2)Patients whose lesions are not safely punctured by EUS
3)No informed consent
Target sample size
90
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Rintaro Mikata |
Organization
Chiba University Hospital
Division name
Gastroenterology
Zip code
Address
1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan
TEL
043-222-7171
mikata@faculty.chiba-u.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Junichi Senoo |
Organization
Chiba University Hospital
Division name
Gastroenterology
Zip code
Address
1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan
TEL
043-222-7171
Homepage URL
adka2742@chiba-u.jp
Sponsor or person
Institute
Graduate School of Medicine, Chiba University
Institute
Department
Personal name
Funding Source
Organization
Chiba University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 12 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 11 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 12 | Month | 14 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
To examine the usefulness of IMP3 and p53 immunohistochemical staining in EUS-FNA samples for pancreatic solid masses.
Management information
Registered date
| 2015 | Year | 12 | Month | 16 | Day |
Last modified on
| 2017 | Year | 08 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023358
